A phase II trial of thalidomide (Thal) and procarbazine (Pro) in adults with recurrent or progressive malignant gliomas (MG)

被引：0
|
作者：
Lesser, G. J. [1 ]
Stieber, V. [1 ]
Case, D. [1 ]
Enevold, G. [1 ]
Rosdhal, R. [1 ]
Tatter, S. [1 ]
Ellis, T. [1 ]
McMullen, K. [1 ]
Shaw, E. [1 ]
机构：
[1] Wake Forest Univ, Winston Salem, NC 27109 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2067
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomas
    Ruiz, Jimmy
    Case, Doug
    Enevold, Gina
    Rosdhal, Robin
    Tatter, Stephen B.
    Ellis, Thomas L.
    McQuellon, Richard P.
    McMullen, Kevin P.
    Stieber, Volker W.
    Shaw, Edward G.
    Lesser, Glenn J.
    JOURNAL OF NEURO-ONCOLOGY, 2012, 106 (03) : 611 - 617
  • [2] A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomas
    Jimmy Ruiz
    Doug Case
    Gina Enevold
    Robin Rosdhal
    Stephen B. Tatter
    Thomas L. Ellis
    Richard P. McQuellon
    Kevin P. McMullen
    Volker W. Stieber
    Edward G. Shaw
    Glenn J. Lesser
    Journal of Neuro-Oncology, 2012, 106 : 611 - 617
  • [3] PHASE II TRIAL OF TALAMPANEL, A GLUTAMATE RECEPTOR INHIBITOR, FOR ADULTS WITH RECURRENT MALIGNANT GLIOMAS
    Iwamoto, Fabio M.
    NEURO-ONCOLOGY, 2009, 11 (05) : 624 - 624
  • [4] Phase II trial of thalidomide (TD), tamoxifen (TX), and temozolomide (T) for patients with advanced malignant gliomas (MG).
    Ahmed, T
    Chen, B
    Rabbani, G
    Wallam, MN
    Benzil, D
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 132S - 132S
  • [5] Lenalidomide and irinotecan in adults with recurrent malignant gliomas: Phase I results of the phase I/II trial
    Puduvalli, Vinay K.
    Groves, Morris D.
    Gilbert, Mark R.
    Hess, Kenneth R.
    Kang, Sanghee
    Ictech, Sandra
    Conrad, Charles A.
    Loghin, Monica Elena
    De Groot, John Frederick
    Levin, Victor A.
    Yung, W. K. Alfred
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults
    Kesari, Santosh
    Schiff, David
    Doherty, Lisa
    Gigas, Debra C.
    Batchelor, Tracy T.
    Muzikansky, Alona
    O'Neill, Alison
    Drappatz, Jan
    Chen-Plotkin, Alice S.
    Ramakrishna, Naren
    Weiss, Stephanie E.
    Levy, Brenda
    Bradshaw, Joanna
    Kracher, Jean
    Laforme, Andrea
    Black, Peter McL.
    Folkman, Judah
    Kieran, Mark
    Wen, Patrick Y.
    NEURO-ONCOLOGY, 2007, 9 (03) : 354 - 363
  • [7] Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme
    Puduvalli, Vinay K.
    Giglio, Pierre
    Groves, Morris D.
    Hess, Kenneth R.
    Gilbert, Mark R.
    Mahankali, Srikanth
    Jackson, Edward F.
    Levin, Victor A.
    Conrad, Charles A.
    Hsu, Sigmund H.
    Colman, Howard
    de Groot, John F.
    Ritterhouse, MeLesa G.
    Ictech, Sandra E.
    Yung, W. K. Alfred
    NEURO-ONCOLOGY, 2008, 10 (02) : 216 - 222
  • [8] A phase II trial of DTIC with thalidomide (thal) in metastatic melanoma (MM).
    Fink, M
    Pavlick, AC
    Bailes, A
    Farrell, K
    Volm, M
    Oratz, R
    Muggia, F
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 720S - 720S
  • [9] A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas
    Odia, Yazmin
    Kreisl, Teri N.
    Aregawi, Dawit
    Innis, Ellen K.
    Fine, Howard A.
    JOURNAL OF NEURO-ONCOLOGY, 2015, 125 (01) : 191 - 195
  • [10] A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas
    Yazmín Odia
    Teri N. Kreisl
    Dawit Aregawi
    Ellen K. Innis
    Howard A. Fine
    Journal of Neuro-Oncology, 2015, 125 : 191 - 195
12345